Discover 1,807 paid clinical trials in Escondido, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,807
Active & Responsive
A Study of TAK-360 in Adults With Idiopathic Hypersomnia
for
Idiopathic Hypersomnia
Location: Santa Ana CA, Redwood City CA, Colorado Springs CO,
Sponsor: Takeda
Sex: All
Age: 18 - 70
Code: NCT06812078
Phase 2, Recruiting
Active & Responsive
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
for
HIV Infections
Location: San Diego CA, Los Angeles CA, West Hollywood CA,
Sponsor: ViiV Healthcare
Sex: All
Age: 12+
Code: NCT07650916
Phase 3, Recruiting
Active & Responsive
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
for
Diabetes Mellitus, Type 2, PreDiabetes, Metabolic Syndrome
Location: La Jolla CA, Chula Vista CA, Orange CA, Indian Wells CA,
Sponsor: Cleerly, Inc.
Sex: All
Age: 55+
Code: NCT06112418
Recruiting
Active & Responsive
Examination of Nociscan Impact on Low Back Pain Surgical Outcomes
for
Low Back Pain
Location: La Jolla CA, Los Angeles CA, Beverly Hills CA,
Sponsor: Aclarion
Sex: All
Age: 18 - 70
Code: NCT06661850
Recruiting
Active & Responsive
A Post-Market Assessment of the Safety and Performance of the TriClip™ System
for
Tricuspid Regurgitation (TR)
Location: La Jolla CA, Phoenix AZ, Austin TX, Chicago IL,
Sponsor: Abbott Medical Devices
Sex: All
Age: 18+
Code: NCT07586995
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Encore PFO Closure Device - The PerFOrm Trial
for
Patent Foramen Ovale, Cryptogenic Stroke
Location: La Jolla CA, Omaha NE, Kansas City KS,
Sponsor: Encore Medical Inc.
Sex: All
Age: 18 - 60
Code: NCT05537753
Recruiting
Active & ResponsiveNew
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
for
Diabetes Mellitus, Type 2
Location: La Jolla CA, San Diego CA, Fountain Valley CA,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07817251
Phase 3, Recruiting
Active & Responsive
Effect of Dupilumab on the Muscle Function of the Esophagus (food Pipe) in Participants with Eosinophilic Esophagitis (EoE)
for
Eosinophilic Esophagitis (EoE)
Location: La Jolla CA
Sponsor: University of California, San Diego
Sex: All
Age: 22+
Code: NCT06665971
Recruiting
Active & Responsive
A Study to Evaluate Efficacy and Safety of Light Dose in Subjects With PWB Treated With Hemoporfin PDT
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: La Jolla CA, Los Angeles CA, Phoenix AZ, Stanford CA,
Sponsor: Bicara Therapeutics
Sex: All
Age: 18+
Code: NCT06788990
Phase 2, Phase 3, Recruiting
Active & Responsive
A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment
for
Wrinkle, Lax Skin, Lines Skin
Location: San Diego CA, Sacramento CA, Houston TX, Chicago IL,
Sponsor: Bausch Health Americas, Inc.
Sex: All
Age: 30 - 60
Code: NCT07187297
Recruiting
Active & Responsive
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
for
Metastatic Dedifferentiated Liposarcoma,
Location: La Jolla CA, Newport Beach CA, Los Angeles CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06422806
Phase 3, Recruiting
Active & Responsive
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Location: La Jolla CA, Los Angeles CA, Gilbert AZ, Seattle WA,
Sponsor: A2 Biotherapeutics Inc.
Sex: All
Age: 18+
Code: NCT06682793
Phase 1, Phase 2, Recruiting
Active & Responsive
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
for
Platinum-resistant Ovarian Cancer,
Location: La Jolla CA, Newport Beach CA, Orange CA, Duarte CA,
Sponsor: Genelux Corporation
Sex: Female
Age: 18+
Code: NCT05281471
Phase 3, Recruiting
Active & Responsive
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Location: La Jolla CA, Laguna Hills CA, Palm Springs CA,
Sponsor: GT Medical Technologies, Inc.
Sex: All
Age: 0+
Code: NCT04427384
Recruiting
Active & Responsive
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
for
PIK3CA Mutation, HER2- Negative Breast Cancer,
Location: San Diego CA, Duarte CA, Beverly Hills CA,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06982521
Phase 3, Recruiting
Active & ResponsiveNew
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
for
Cutaneous Melanoma
Location: La Jolla CA, Irvine CA, Loma Linda CA, Orange CA,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 70+
Code: NCT07068074
Phase 3, Recruiting
Active & Responsive
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
for
Solid Tumor, Adult, Colorectal Cancer, NSCLC,
Location: La Jolla CA, Los Angeles CA, Gilbert AZ, Stanford CA,
Sponsor: A2 Biotherapeutics Inc.
Sex: All
Age: 18+
Code: NCT06051695
Phase 1, Phase 2, Recruiting
Active & Responsive
Multisite Implementation of COMPRENDO
for
Pediatric Cancer
Location: San Diego CA, San Francisco CA, Birmingham AL,
Sponsor: University of California, San Diego
Sex: All
Age: 18+
Code: NCT06055296
Recruiting
Active & Responsive
A Study of Rebecsinib for Patients With Relapsed/Refractory Secondary Acute Myeloid Leukemia or High Risk Myelofibrosis